Skip to main content

Table 5 Assessment of dermatologic lesions using a feline allergic dermatitis (SCORFAD) severity scale for cats naturally infested with fleas in homes in Florida and treated with either a single topical dose of fluralaner or three consecutive monthly doses of selamectin

From: In-home assessment of either topical fluralaner or topical selamectin for flea control in naturally infested cats in West Central Florida, USA

Treatment group

Days post-treatment

0

30

60

84

Fluralaner1

No. of cats

31

31

31

31

Mean SCORFAD Score3

7.5a,x

2.7a,y

1.3a,y

1.1a,y

SD

8.39

3.96

1.77

1.47

Range

(0–28)

(0–18)

(0–7)

(0–6)

% Reduction4

 

63.6

82.8

85.3

Selamectin2

No. of cats

29

29

27

26

Mean SCORFAD Score3

7.7a,x

5.6a,x

3.2a,y

3.4a,y

SD

10.34

8.85

4.73

3.90

Range

(0–50)

(0–35)

(0–21)

(0–13)

% Reduction4

 

26.9

58.1

56.5

  1. 1In the fluralaner group cats were treated once topically on day 0 (Bravecto® Topical solution; Merck Animal Health, Madison, NJ, USA)
  2. 2In the selamectin group cats were treated on day 0 and once between days 28–30 and 56–60 (Revolution®; Zoetis, Whippany, NJ, USA)
  3. 3Arithmetic mean SCORFAD lesion score
  4. 4{(Day 0 arithmetic mean SCORFAD score – day x arithmetic mean SCORFAD score) / day 0 arithmetic mean SCORFAD score)} × 100
  5. a,bArithmetic mean SCORFAD lesion scores in a column with like letter superscripts are not significantly different (P > 0.058; │t│ ≥ 0.21).
  6. x,yArithmetic mean SCORFAD lesion scores in a row with unlike letter superscripts are significantly different from day 0 (P < 0.001; │t│≥ 3.35; day 30 Selamectin vs baseline P = 0.13; t = 1.53)